Named One of 2019’s “Best Entrepreneurial Companies in America” by Entrepreneur Magazine

Share Article featured on Entrepreneur360™ List for Second Consecutive Year

News Image
“Our mission at is to make it possible to cure all human diseases by 2050."—Kevin Lustig, PhD,’s CEO and Founder, the world's premier marketplace for outsourced R&D services, was named one of 2019’s “Best Entrepreneurial Companies in America” by Entrepreneur magazine. The San Diego-based company has built a new type of Business to Enterprise (B2E) marketplace that helps medical scientists at biotech and pharma companies connect with technical experts worldwide and carry out thousands of cutting-edge research experiments.

“Our mission at is to make it possible to cure all human diseases by 2050,” stated Kevin Lustig, PhD,’s CEO and Founder. “B2E marketplaces like can simultaneously shorten the multi-year drug discovery cycle, reduce R&D costs and promote the use of the most innovative tools and technologies.” was ranked #51 on this year’s Entrepreneur360 list of the “Best Entrepreneurial Companies in America.” Rankings were based on an algorithm built on a balanced scorecard of five metrics: innovation, growth, leadership, impact and business valuation. In 2018, was ranked #12 on the list.

To view the entire E360 List, visit:

About is the world's premier Business to Enterprise (B2E) marketplace for outsourced R&D. The marketplace simplifies R&D sourcing, saving time and money, reducing risk and providing access to the latest innovative tools and technologies. operates private enterprise marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, has raised $32 million from 5AM Ventures, Leerink Transformation Partners and Heritage Provider Network among others. Visit to learn more.

Join on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram.

Media Contact:
Sean Preci
Director of Communications
+1 858-455-1300, ext. 401

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Preci
Visit website